{
    "clinical_study": {
        "@rank": "119231", 
        "arm_group": [
            {
                "arm_group_label": "Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "AHA diet plus exercise with BIB placement"
            }, 
            {
                "arm_group_label": "Sham control", 
                "arm_group_type": "Sham Comparator", 
                "description": "AHA diet plus exercise with sham BIB placement"
            }
        ], 
        "brief_summary": {
            "textblock": "The study will determine the feasibility of using Bioenteric intragastric balloon (BIB) in\n      the treatment of patients with Non alcoholic Steatohepatitis (NASH)."
        }, 
        "brief_title": "Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)", 
        "completion_date": {
            "#text": "September 2008", 
            "@type": "Actual"
        }, 
        "condition": "Non Alcoholic Steatohepatitis", 
        "condition_browse": {
            "mesh_term": "Fatty Liver"
        }, 
        "detailed_description": {
            "textblock": "The Bio-enteric Intra-gastric balloon (BIB) has been shown to be an effective treatment for\n      weight reduction in obese patients. This study will determine the feasibility of using BIB\n      in the treatment of patients with Non alcoholic Steatohepatitis (NASH). It will evaluate the\n      efficacy of the BIB in improving histology of NASH in obese patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients between 21-65 years of age,\n\n          -  Had histological evidence of NASH,\n\n          -  Had a BMI of greater than 27kg/m2, and\n\n          -  Had failed at least 6 month trial of medical therapy for weight reduction.\n\n        Exclusion Criteria:\n\n          -  Patients with any organic disease of the upper GI tract,\n\n          -  Were receiving anti-inflammatory drugs,\n\n          -  Anticoagulants or steroids, or\n\n          -  Had a history of alcoholism or drug addiction. A hiatus hernia of > 5 cm, an active\n             gastric or duodenal ulcer, and prior or intestinal surgery were considered\n             contraindications to the placement of BIB."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761370", 
            "org_study_id": "D/05/338"
        }, 
        "intervention": [
            {
                "arm_group_label": "Treatment", 
                "description": "AHA diet plus exercise with BIB placement for 6 months", 
                "intervention_name": "AHA diet plus exercise with BIB placement", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Sham control", 
                "description": "AHA diet plus exercise with sham BIB placement", 
                "intervention_name": "AHA diet plus exercise with sham BIB placement", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Non alcoholic Steatohepatitis", 
            "Intra-gastric balloon"
        ], 
        "lastchanged_date": "January 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Singapore", 
                    "country": "Singapore", 
                    "zip": "119074"
                }, 
                "name": "National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Singapore"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)", 
        "overall_official": {
            "affiliation": "National University Hospital, Singapore", 
            "last_name": "Yin Mei Lee, MBChB", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Singapore: Domain Specific Review Boards", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure was liver histology before and after treatment. Assessment of disease activity was done with the use of the NAS, which grades  steatosis, lobular inflammation and hepatocellular ballooning.", 
            "measure": "Change in liver histology", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761370"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National University Hospital, Singapore", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National University Hospital, Singapore", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2005", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2011"
    }
}